House and Senate Pass Mental Health Parity Extension
Client Alert | less than 1 min read | 12.22.03
The House and Senate have each passed bills that would extend the applicability of the Mental Health Parity Act of 1996 ("MHPA") an additional year. The Senate version, S. 1929, passed by unanimous consent. MHPA, the provisions of which appear in Section 702 of ERISA, was scheduled to expire as of December 31, 2003. MHPA requires group health plans to provide annual and lifetime limits on mental health benefits that are identical to those provided by the plan for major medical benefits. Small employers-generally those with 50 or fewer employees-are exempt from MHPA's requirements.
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
